Beta Renewables and Novozymes to form strategic partnership in the cellulosic biofuel market
Novozymes, the world's largest producer of industrial enzymes, and Beta Renewables, a global leader in cellulosic biofuels and part of Gruppo Mossi & Ghisolfi, today announce an agreement to jointly market, demonstrate and guarantee cellulosic biofuel solutions.
Wilmington, North Carolina (PRWEB) October 29, 2012
Companies enter into strategic partnership making Novozymes the preferred enzyme supplier for Beta Renewables' current and future cellulosic biofuel projects.
Novozymes, the world's largest producer of industrial enzymes, and Beta Renewables, a global leader in cellulosic biofuels and part of Gruppo Mossi & Ghisolfi, today announce an agreement to jointly market, demonstrate and guarantee cellulosic biofuel solutions. As part of the agreement, Novozymes will acquire a 10% share in Beta Renewables, paying approximately $115 million cash for the equity, marketing fees, other intellectual property rights and milestone payments.
The partners will offer customers looking to produce biofuels from agricultural residues, energy crops and other cellulosic feedstocks a combination of Novozymes' Cellic® enzymes and Beta Renewables' PROESA™ engineering and production technology. Beta Renewables will embed Novozymes' enzymes in the PROESA technology and guarantee biofuel production costs upon start-up of customers' cellulosic facilities. The deal is unique in offering a combined solution that reduces the risk in customers' projects while providing competitive commercial terms.
“This type of complete offering will significantly de-risk cellulosic biofuel projects financially as well as technologically for our customers,” says Beta Renewables' Chairman and CEO, Guido Ghisolfi. “It will make cellulosic biofuel projects bankable and accelerate large-scale commercialization of the industry.”
“Large-scale commercialization of cellulosic biofuels is taking off, and this is a fantastic opportunity for Novozymes,” says Peder Holk Nielsen, Executive Vice President at Novozymes. “Beta Renewables is an extremely committed industry front-runner. They are building advanced biofuel facilities all over the world and, by being their preferred enzyme supplier, Novozymes will gain access to significant new business opportunities. We expect Beta Renewables to be able to contract 15-25 new facilities within the next three to five years. The sales potential for Novozymes from these plants could be up to $175 million.”
World's largest advanced biofuel plant
In the last five years, Beta Renewables has invested over $200 million (€140 million) in development of the cost-competitive PROESA process. PROESA is the same technology that will be used at the world's largest cellulosic ethanol plant in Crescentino, Italy, where operations are expected to start by the end of 2012. The plant will initially produce 13 million gallons (50 million liters) of ethanol per year from wheat straw, energy crops and other locally available feedstocks. It has a design capacity of 20 million gallons (76 million liters) per year.
“Just one year after it was established, Beta Renewables has become a global leader in the production of non-food biofuels and biochemicals,” says Guido Ghisolfi. “This agreement has double value: It demonstrates the full integration of the PROESA process with the enzyme technology and allows Beta Renewables to guarantee a full lignocellulosic cost.”
Beta Renewables has also secured a deal to build at least one manufacturing plant in Brazil with GraalBio, and, recently, Gruppo Mossi & Ghisolfi received a $99 million loan guarantee from the U.S. Department of Agriculture to construct Project Alpha, a cellulosic biofuel plant in North Carolina.
Novozymes is the world's leading supplier of enzymes to the biofuel industry. The Denmark-based biotech company's Cellic enzymes enable cost-efficient conversion of biomass to ethanol and are broadly regarded as the industry benchmark.
Today, Oct. 29, 2012, Novozymes will host a conference call for investors, analysts and media at 5:45-6:30 p.m. CET/12:45-1:30 p.m. EDT. The call can be accessed via http://www.novozymes.com/en/investor/events-presentations/Pages/conference-call.aspx or by dialing:
Denmark: +45 3272 8018, UK: +44 1452 555 131, USA: +1 8666 828 490
Industry and media briefing
Also today, Novozymes Executive Vice President Peder Holk Nielsen and Beta Renewables Chairman and CEO Guido Ghisolfi will discuss details of the partnership at a briefing for industry and media at the Advanced Biofuels Markets Conference in San Francisco, California. The briefing takes place in the Divisadero room of the Parc 55 Hotel at 4:15-5:00 p.m. PDT.
Novozymes is the world leader in bioinnovation. Together with customers across a broad array of industries we create tomorrow's industrial biosolutions, improving our customers' business and the use of our planet's resources.
With over 700 products used in 130 countries, Novozymes' bioinnovations improve industrial performance and safeguard the world's resources by offering superior and sustainable solutions for tomorrow's ever-changing marketplace. Read more at http://www.novozymes.com.
About Beta Renewables
Beta Renewables is the leader in making non-food cellulosic biomass practical and cost-competitive for the production of advanced biofuels and biochemicals. Beta Renewables is a unique $350 million (€250 million) joint venture formed from the Chemtex engineering division of Gruppo Mossi & Ghisolfi, and TPG. The M&G Group is one of the world's leading producers of PET resin and is Italy's second largest chemical company. The Group has operations in Brazil, Mexico, China, India, the USA and Italy. The company has over 60 years of success in process development and commercializing hundreds of plants worldwide. Beta Renewables has invested over $200 million (€140 million) in the development of the PROESA™ process. The company is currently building the world's first commercial-scale cellulosic ethanol facility in Crescentino, Italy, expected to start operations by the end of 2012.
For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2012/10/prweb10066203.htmView Comments and Join the Discussion!